Skip to content

A Clinical Trial to study the effects of Lekhana Basti (medicated Enema) and drug- Trayushnadya Loha in patients with Obesity

A COMPARATIVE CLINICAL TRIAL EVALUATING THE THERAPEUTIC EFFECT OF LEKHANA BASTI AND TRAYUSHNADYA LOHA IN STHAULYA w.s.r. TO OBESITY

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027026
Enrollment
90
Registered
2020-08-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E663- Overweight

Interventions

Intervention1: Lekhana Basti, Trayushnadya Loha Vati, Lekhana Basti and Trayushnadya Loha Vati: Group I- Intervention: Lekhana Basti, Duration 24 days (8 +16), Follow up on Day- 42 & Day- 56,Total dur
Group II â?? Intervention: Trayushnadya Loha 2 Vati of 500mg twice a Day, before food for 24 days, Follow up on Day- 42 & Day- 56, Total duration 56 days/8 weeks
Group III- Intervention: Lekhana Basti and Trayushnadya Loha (2 Vati of 500mg twice a Day, before food) for 24 days, Follow up on Day- 42 & Day- 56, Total duration 56 days/8 weeks. Control Interventio

Sponsors

Dr Ramesh Prasad Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with classical features of Sthaulya. Patients having BMI more than or equal to 30 kg/m2 Patients of either gender between the groups of 20-60 years. Patients fit for Basti karma.

Exclusion criteria

Exclusion criteria: Patients not fulfilling the inclusion criteria. Patients having associated complication like cardiac diseases. Patients having Sthaulya due to endocrine or genetic abnormalities Patients having fissure, fistula and hemorrhoids.

Design outcomes

Primary

MeasureTime frame
Complete Remission- 100% relief in the signs and symptoms Marked Improvement- More than 75% relief in the signs and symptoms Moderate Improvement- 50-74% relief in the signs and symptoms Mild Improvement- 25-50% relief in signs and symptomsTimepoint: Total Duration- 56 days

Secondary

MeasureTime frame
NONETimepoint: NIL

Countries

India

Contacts

Public ContactRAMESH PRASAD GUPTA

Kriya Sharir Department

bbkhuntia69@gmail.com9437499423

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026